ConductScience.org, home

Paper31209005

Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.

Viljoen A and 6 others. Antimicrob Agents Chemother, 2019. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages. Papers, record 31209005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31209005

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
1.17
iCite
Revised in PubMed
2020-07-17
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Viljoen AAlbertushttps://orcid.org/0000-0001-8949-7401
2Raynaud CClément
3Johansen MDMatt Dhttps://orcid.org/0000-0001-5553-5270
4Roquet-Banères FFrançoise
5Herrmann JLJean-Louis
6Daher WWassim
7Kremer LLaurenthttps://orcid.org/0000-0002-6604-4458

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
DiarylquinolinesMajor topic
Mycobacterium Infections, NontuberculousMajor topic
Mycobacterium abscessusMajor topic
VerapamilMajor topic
Antitubercular Agents
Bacterial Proteins
Cell Line
Drug Resistance, Bacterial
Drug Synergism
Humans
Macrophages
Microbial Sensitivity Tests
Mutation

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125010492Acquired resistance of Mycobacterium tuberculosis to bedaquiline.PLoS One2014https://conductscience.org/library/papers/25010492PubMed
224567393Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/24567393PubMed
328807917Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28807917PubMed
425331694Verapamil increases the bactericidal activity of bedaquiline against Mycobacterium tuberculosis in a mouse model.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/25331694PubMed
528242674In Vitro Activity of Bedaquiline against Nontuberculous Mycobacteria in China.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28242674PubMed
625283255Treatment for calcium channel blocker poisoning: a systematic review.Clin Toxicol (Phila)2014https://conductscience.org/library/papers/25283255PubMed
729038265Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29038265PubMed
828096155Inhibition of the β-Lactamase BlaMab by Avibactam Improves the In Vitro and In Vivo Efficacy of Imipenem against Mycobacterium abscessus.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28096155PubMed
924126586Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24126586PubMed
1021292659Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease.Clin Infect Dis2011https://conductscience.org/library/papers/21292659PubMed
1129463541Verapamil Targets Membrane Energetics in Mycobacterium tuberculosis.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29463541PubMed
1226678435US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary.Thorax2016https://conductscience.org/library/papers/26678435PubMed
1317277290An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.Am J Respir Crit Care Med2007https://conductscience.org/library/papers/17277290PubMed
1430323043Mutations in the MAB_2299c TetR Regulator Confer Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/30323043PubMed
1517525564Verapamil toxicity: an unusual case report and review of the literature.Am J Forensic Med Pathol2007https://conductscience.org/library/papers/17525564PubMed
1620071249Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis.J Cyst Fibros2010https://conductscience.org/library/papers/20071249PubMed
1724532601Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs.J Infect Dis2014https://conductscience.org/library/papers/24532601PubMed
1826214350The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United States.Ann Am Thorac Soc2015https://conductscience.org/library/papers/26214350PubMed
1920521931TMC207: the first compound of a new class of potent anti-tuberculosis drugs.Future Microbiol2010https://conductscience.org/library/papers/20521931PubMed
2024515248Genomic reconnaissance of clinical isolates of emerging human pathogen Mycobacterium abscessus reveals high evolutionary potential.Sci Rep2014https://conductscience.org/library/papers/24515248PubMed

See all 26 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
41767945CRISPR-based genome editing reveals the roles of efflux pumps in Mycobacterium abscessus.mLife2026https://conductscience.org/library/papers/41767945PubMed
41155175Beyond Antibiotics: Repurposing Non-Antibiotic Drugs as Novel Antibacterial Agents to Combat Resistance.Int J Mol Sci2025https://conductscience.org/library/papers/41155175PubMed
40709198Interactions between gut microbiota and cardiovascular drugs: effects on drug therapeutic effect and side effect.Front Cardiovasc Med2025https://conductscience.org/library/papers/40709198PubMed
39766559Mycobacterium tuberculosis F-ATP Synthase Inhibitors and Targets.Antibiotics (Basel)2024https://conductscience.org/library/papers/39766559PubMed
38572960Efflux pump effects on levofloxacin resistance in Mycobacterium abscessus.Antimicrob Agents Chemother2024https://conductscience.org/library/papers/38572960PubMed
36902066Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options.Int J Mol Sci2023https://conductscience.org/library/papers/36902066PubMed
35420492In Vitro Bedaquiline and Clofazimine Susceptibility Testing in Mycobacterium abscessus.Antimicrob Agents Chemother2022https://conductscience.org/library/papers/35420492PubMed
34526902Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus.Front Pharmacol2021https://conductscience.org/library/papers/34526902PubMed
33790590Carbonyl Cyanide 3-Chlorophenylhydrazone (CCCP) Exhibits Direct Antibacterial Activity Against Mycobacterium abscessus.Infect Drug Resist2021https://conductscience.org/library/papers/33790590PubMed
33645845Pipeline of anti-Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities.Med Res Rev2021https://conductscience.org/library/papers/33645845PubMed
33565103Host-directed therapy to combat mycobacterial infections.Immunol Rev2021https://conductscience.org/library/papers/33565103PubMed
33325009Are antibacterial effects of non-antibiotic drugs random or purposeful because of a common evolutionary origin of bacterial and mammalian targets?Infection2021https://conductscience.org/library/papers/33325009PubMed
33042066In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates.Front Microbiol2020https://conductscience.org/library/papers/33042066PubMed
32253217Efficacy of Bedaquiline, Alone or in Combination with Imipenem, against Mycobacterium abscessus in C3HeB/FeJ Mice.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/32253217PubMed
32086501Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus.Nat Rev Microbiol2020https://conductscience.org/library/papers/32086501PubMed
32041716Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/32041716PubMed
31766758Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients.Int J Mol Sci2019https://conductscience.org/library/papers/31766758PubMed
31332077The TetR Family Transcription Factor MAB_2299c Regulates the Expression of Two Distinct MmpS-MmpL Efflux Pumps Involved in Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/31332077PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31209005

GET https://conductscience.org/api/papers/v1/31209005/references?page=2